Int J Curr Pharm Res, Vol 12, Issue 1, 10-13Original Article


MICROWAVE ASSISTED SYNTHESIS OF TETRAHYDROPYRMIDINE AND IN SILICO SCREENING OF ANTIDIABETIC DRUG

GEJALAKSHMI S.*, HARIKRISHNAN N.1, THILLAI GOVINDARAJAN G. E., DIVYASRI A.

Faculty of Pharmacy, Department of Pharmaceutical Chemistry, DR. M. G. R. Educational and Research Institute, Velappanchavadi, Chennai-77
Email: gejampharm@gmail.com

Received: 15 Sep 2019, Revised and Accepted: 25 Nov 2019


ABSTRACT

Objective: To detect the microwave-assisted synthesis of Tetrahydropyrimidine derivative and its molecular docking studies for Diabetes.

Methods: The Bignelli condensation method was used for Tetrahydropyrimidine derivative synthesis. The docking studies made in Argus Lab software.

Results: The Tetrahydropyrimidine is synthesized using the microwave. The Tetrahydropyrimidine derivative is found to be attack the insulin receptor, as it the tendency of binding with insulin receptor showed in Argus lab. Further, the good binding site of Tetrahydropyrimidine derivative with insulin receptor was predicted.

Conclusion: From the research work, The Tetrahydropyrimidine derivative shows its affinity to bind with the insulin receptor. The binding value is averagely 7 which indicates it can attraction with the receptor, so it can control Diabetic mellitus by altering insulin secretion in blood plasma.

Keywords: Tetrahydropyrimidine, Microwave-assisted synthesis, Molecular docking study, Antidiabetic activity


INTRODUCTION

Diabetes mellitus is characterised by abnormally high levels of glucose in the blood due to an abnormal level of insulin secretion [1]. The diabetes shows the combined effect of hyperglycaemic with long period damage or malfunction or death of some organ [2]. Several pathogenic process are involved in the development of diabetes. Diabetes affected more 425 million people in the world, In India more than 742,946,400 case were studied in adult [3]. Diabetes is mainly classified as two types; 1) Type- Diabetes which is complete destruction of insulin, 2) Type- Diabetes which is inadequate supply of insulin [4]. Diabetes is treated by oral medication and lifestyle modification, oral medication is based on providing blood glucose lowering drug [5].

Tetrahydropyrimidine derivative synthesis based on the bignelli condensation prepared on microwave assistant [6]. Tetrahydropyrimidine derivatives can act as anthelmintics [7], antiparasitic [8], antibacterial [9] and show muscarinic activity [10]. The concept of green synthesis principle have made more attention of fine chemicals and pharmaceutical industries on preparation of organic products. The green synthesis produce less toxic and safe reagents. Green synthesis has been identified as eco-friendly technique of formulations [11]. Microwave assisted synthesis comparatively beneficial than conventional synthesis, in conventional method need of large solvent, long time taken to get heated, spread bad odour where these can be reduced in microwave assisted synthesis [12].

Molecular docking studied are mainly made to find the interaction of ligand receptor binding by the computational method [13]. Molecular docking study helps to design and discover the drug and to study the binding in DNA/RNA site [14]. Ligand fitting into binding site due to hydrophobic and electrostatic interaction gives the free binding energy [15].

Synthesis

It is based on the Bignelli Condensation. The equimolar mixture of aromatic aldehyde (benzaldehyde), ethyl acetoacetate and urea were taken in a round bottom flask. To the mixture concentrated hydrochloride acid is added, converted into china dish kept in microwave 180watts for 1 minute, recrystallized by ethanol [16].

MATERIALS AND METHODS

Preparation of ligand

The green synthesis of Tetrahydropyrimidine derivative namely Ethyl 4-methyl-2-oxo-6-phenyl-3, 4-dihydro-1H-pyrimidine-5-carboxylate [17] is chosen as the ligand. The ligand structure is initially drawn in Chemsketch software, and its 3d structure is viewed in Argus lab.

Preparation of protein

The crystal structure of phosphorylated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analogue receptor was downloaded from RCSB PDB (http://www.rcsb.org), it consists of code 1IR3 [18]. The downloaded receptor is viewed in chimera 1.13.1.

Molecular docking

The Ethyl 4-methyl-2-oxo-6-phenyl-3, 4-dihydro-1H-pyrimidine-5-carboxylate ligand is viewed in Argus lab, and selected as ligand group. The phosphorylated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analogue receptor is viewed in chimera, remove the complexed compound present in the receptor, further view it in Argus lab and add hydrogen to the receptor so as to increase affinity. The amino acid binding site were selected from earlier literature and the binding sites namely 1079 MET, 1150 ASP, 1006SER, 1083 ASP, 1081 HIS, 1108 GLU, 1077 GLU [19]. The docking of receptor-ligand was made on Argus lab software [20]. The binding made with grid dimension (x, y, z) = (39×39×39). The best ligand pose energy was found and for every binding site and viewed in Pymol viewer.

RESULTS AND DISCUSSION

Table 1: Docking score and binding site

S. No. Rank Binding site Best ligand pose energy (kcal/mol) Cluster poses
1 1 1079 MET -9.13544 50
2 2 1150 ASP -8.03805 24
3 3 1006 SER -7.62575 60
4 4 1083 ASP -7.58741 68
5 5 1081 HIS -7.51747 50
6 6 1108 GLU -5.44869 63
7 7 1077 GLU -5.00426 18

Ligand: Tertrahydropyrimidine

Fig. 1: Ethyl 4-methyl-2-oxo-6-phenyl-3, 4-dihydro-1H-pyrimidine-5-carboxlate

Fig. 2: 1079MET Fig. 3: 1150ASP

Fig. 4: 1006SER Fig. 5:1083ASP

Fig. 6: 1081HIS Fig. 7: 1108GLU

The docking study made to determine protein and ligand binding energy and capacity [20]. The main reason for the study is to determine the Tetrahydropyrimidine derivative compound can attach to insulin receptor and can increase insulin production, hence the Tetrahydropyrimidine compound forms interaction with insulin. Argus lab docking reports gives the best ligand pose energy and these energy values are arranged in lower value order. The ligand binded with amino acid namely 1079 MET, 1150 ASP, 1006 SER, 1083 ASP, 1081 HIS, 1108 GLU, 1077 GLU and possess energy-9.13544,-8.03805,-7.62575,-7.58741,-7.51747,-5.44869,-5.00426 respectively. It shows that the tetrahydropyrimidine derivative can be used for insulin secretion.

Fig. 8: 1077GLU

CONCLUSION

The docking study shows that tetrahydro pyrimidone derivative produced by green synthesis preparation is can use for the treatment of diabetic as it can increase insulin secretion.

FUNDING

Nil

AUTHORS CONTRIBUTIONS

All the authors have contributed equally.

CONCLUSION OF INTERESTS

The authors confirm that this article content has no conflict of interest.

REFERENCES

  1. Darwish, Akram T Kharroubi, Hisham M. Diabetes mellitus: the epidemic of the century. World J Diabetes 2015;6:850-67.

  2. Association, American Diabetes. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62–S69.

  3. Federation, IDF-International Diabetes. Available from: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. [Last accessed on 10 Aug 2019]

  4. Carolina Solis Herrera, MD Curtis Triplitt Pharm D, Charles Reasner MD, Ralph A DeFronzo MD, Eugenio Cersosimo MD PhD. Classification of diabetes mellitus MD. Available from: text.com.inc. South Dartmouth (MA) [Last accessed on 24 Apr 2015].

  5. Minu M George MD, Kenneth C Copeland MD. Current treatment options for type 2 diabetes mellitus in youth: today’s realities and lessons from today study. Curr Diab Rep 2013;13:72–80.

  6. Aspinall SR. A synthesis of tetrahydro pyrimidines. J Am Chem Soc 1940;1:2160–2.

  7. Ruben Vardanyan, Victor Hruby. Synthesis of best-seller drugs. chapter-36. Anthelmintics 2016. p. 749-64.

  8. Hamid Beyzaei, Reza Aryan, Zahra Keshtegar. Synthesis of new imidazolidine and tetrahydro pyrimidone derivatives. Adv Chem 2014. http://dx.doi.org/10.1155/2014/834641

  9. Naser Foroughifar, Somayeh Karimi Beromi, Hoda Pasdar, Masoumeh Shahi. Synthesis of some new tetrahydro pyrimidone derivatives as possible antibacterial agents. Iran J Pharm Res 2017;16:596–601.

  10. Jung MH, Park JG, Yang KJ, Lee MJ. Synthesis and muscarinic activity of 1,2,3,4-tetrahydro pyrimidone derivatives. Arch Pharm (Weinheim) 2001;334:79-85.

  11. Khadeeja Parveen, Viktoria Banse, Lalita Ledwani. Green synthesis of nanoparticles: their advantages and disadvantages. Am Inst Phys Conf Proc 2016;1724:020048.

  12. Ajmer Singh Grewal, Karunesh Kumar, Karunesh Kumar, Sonika Redhu. Microwave-assisted synthesis: a green chemistry approach. Int Res J Pharm Appl Sci 2013;3:278-85.

  13. Xuan-Yu Meng, 1,2 Hong-Xing Zhang, Mihaly Mezei, Meng Cui. Molecular Docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 2011;7:146-57.

  14. Ayaz Mahmood Dar, Shafia Mi. Molecular docking: approaches, types, applications and basic challenges. J Anal Bioanal Tech 2017;8:2.

  15. Aaftaab Sethi, Khusbhoo Joshi, K Sasikala, Mallika Alvala. Molecular docking in modern drug discovery: principles and recent applications. In: tech Open; 2019.

  16. Amit G Nerkar, Dhanashri Pawale, Minal R Ghante, Sanjay D Sawant. Microwave-assisted organic synthesis of some traditional and named reactions: a practical approach of green chemistry. Int J Pharm Pharm Sci 2013;5:564-6.

  17. http://www.chemspider.com/Chemical-Structure.75542626.html?rid=77b2b4e0-a039-4865-a4d2-8a85fd928a0a.Chemspider. [Last accessed on 10 Aug 2019]

  18. Hubbard SR. Phosphorylated insulin receptor tyrosine kinase in complex with peptide substrate and atp analog. RCSB PDB; 1998. Available from: https://www.rcsb.org/structure/1ir3. [Last accessed on 10 Aug 2019]

  19. Swarna, Jayasree Ganugapati, Sruthi. Molecular docking studies of antidiabetic activity of cinnamon compounds. Asian J Pharm Clin Res 2014;7(Suppl 2):31-4.

  20. Manya Sharma, Pradeep Kumar Naik. To study the mode and mechanism of interaction of angiopoietin II with receptor tyrosine kinase Tie-2 using molecular mechanics and molecular dynamics approach. Int J Fundamental Appl Sci 2013;2:8-11.